GMC
Showing 1 - 25 of 497
Pneumococcal Disease, Invasive Trial in Denpasar (Walvax PCV13-TT, Pfizer PCV13)
Not yet recruiting
- Pneumococcal Disease, Invasive
- Walvax PCV13-TT
- Pfizer PCV13
-
Denpasar, Bali, IndonesiaDepartemen Ilmu Kesehatan Anak FK Unud
Jun 28, 2023
Primary Open Angle Glaucoma, Ocular Hypertension Trial in India, Russian Federation (Brinzolamide ophthalmic suspension, Azopt®)
Recruiting
- Primary Open Angle Glaucoma
- Ocular Hypertension
- Brinzolamide ophthalmic suspension
- Azopt®
-
Srikakulam, Andhra Pradesh, India
- +38 more
Dec 23, 2022
Pneumococcal Disease Trial in Chengdu (23-valent pneumococcal polysaccharide vaccine, control pneumococcal polysaccharide
Recruiting
- Pneumococcal Disease
- 23-valent pneumococcal polysaccharide vaccine
- control pneumococcal polysaccharide vaccine
-
Chengdu, Sichuan, ChinaSichuan Center For Disease Control and Prevention
Sep 19, 2023
Tetanus Trial in Shangqiu (Investigational tetanus vaccine, adsorbed, Control tetanus vaccine, adsorbed)
Recruiting
- Tetanus
- Investigational tetanus vaccine, adsorbed
- Control tetanus vaccine, adsorbed
-
Shangqiu, Henan, ChinaLiangyuan District Center for Disease Control and Prevention
Sep 15, 2023
Moderna COVID-19 Bivalent Booster for Omicron BA.4/5
Recruiting
- COVID-19
- Moderna COVID-19 Vaccine
- +3 more
-
Culver City, CaliforniaScience37
Mar 9, 2023
SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA Vaccine
- Saline
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023
Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)
Not yet recruiting
- Pneumococcal Vaccines
- IVT PCV-25 Formulation A
- +3 more
-
Vancouver, British Columbia, Canada
- +3 more
Oct 10, 2023
Pneumococcal Vaccines Trial (12-Valent Pneumococcal Conjugate Vaccine)
Not yet recruiting
- Pneumococcal Vaccines
- 12-Valent Pneumococcal Conjugate Vaccine
- (no location specified)
Jan 31, 2023
COVID-19 Trial in Tashkent (Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells), Recombinant Novel
Recruiting
- COVID-19
- Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
- Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
-
Tashkent, UzbekistanUzbekistan, Tashkent city, Said baraka street 10
Nov 11, 2022
SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA Vaccine
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023
Hepatitis A Trial (Healive (hepatitis A vacine(human diploid cell), inactivated))
Not yet recruiting
- Hepatitis A
- Healive (hepatitis A vacine(human diploid cell), inactivated)
- (no location specified)
Sep 21, 2023
Immunogenicity of After Primary Immunization and Booster
Active, not recruiting
- Polio
- no intervention
-
Pingxiang, Jiangxi, ChinaShangli Center for Disease Control and Prevention
Sep 21, 2023
Patient Safety, Inappropriate Prescribing, Medication Errors Trial in United Kingdom (REVISiT intervention)
Completed
- Patient Safety
- +2 more
- REVISiT intervention
-
Derby, Derbyshire, United Kingdom
- +3 more
Dec 21, 2022
Rabies Trial in China (5-dose group of test vaccine, 5-dose group of control vaccine, 4-dose A group of test vaccine)
Not yet recruiting
- Rabies
- 5-dose group of test vaccine
- +3 more
-
Chengdu, Sichuan, China
- +3 more
Jul 23, 2023
Hepatitis A, Hep A Trial in Suwon, Chiang Mai (Boryung Hepatitis A Vaccine Pre-Filled Syringe Inj. 0.5 mL, HAVRIX 720 Junior 0.5
Not yet recruiting
- Hepatitis A
- Hep A
- Boryung Hepatitis A Vaccine Pre-Filled Syringe Inj. 0.5 mL
- HAVRIX 720 Junior 0.5 mL
-
Suwon, Korea, Republic of
- +1 more
Nov 4, 2022
Diphtheria, Tetanus Trial (Clodivac, Td-Impfstoff Merieux)
Not yet recruiting
- Diphtheria
- Tetanus
- Clodivac
- Td-Impfstoff Merieux
- (no location specified)
Aug 9, 2022
Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )
Completed
- Covid19
- SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
- Saline placebo
-
Tehran, Iran, Islamic Republic ofEspinas Palace Hotel
Oct 11, 2022
Vaccine Reaction Trial in Jinhua, Quzhou (vaccinate with DTap, vaccinate with DT)
Not yet recruiting
- Vaccine Reaction
- vaccinate with DTap
- vaccinate with DT
-
Jinhua, Zhejiang, China
- +1 more
May 12, 2023
Vaccine Reaction Trial in Hangzhou, Jiaxing (vaccinate with DTaP, vaccinate with DT)
Not yet recruiting
- Vaccine Reaction
- vaccinate with DTaP
- vaccinate with DT
-
Hangzhou, Zhejiang, China
- +1 more
May 12, 2023
Clostridoides Difficile Associated Disease Trial in United States (C. difficile vaccine (previously studied formulation), C.
Recruiting
- Clostridoides Difficile Associated Disease
- C. difficile vaccine (previously studied formulation)
- +4 more
-
Anaheim, California
- +8 more
Apr 6, 2023
Rabies Vaccine Adverse Reaction Trial in Changsha (Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose
Completed
- Rabies Vaccine Adverse Reaction
- Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose program
- +3 more
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Oct 9, 2023
Pneumococcal Infections Trial in Xiangtan (13-Valent Pneumococcal Polysaccharide Conjugate Vaccine)
Recruiting
- Pneumococcal Infections
- 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
-
Xiangtan, Hunan, ChinaXiangtan Maternal and Child Health Hospital
Nov 11, 2022
Pneumococcal Infections, Streptococcal Infections, Bacterial Infections Trial in Anyang (13-Valent Pneumococcal Polysaccharide
Active, not recruiting
- Pneumococcal Infections
- +2 more
- 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine（CRM197,TT）
- 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
-
Anyang, Henan, ChinaNeihuang Center for Disease Control and Prevention
Oct 28, 2022
Pneumococcal Infections Trial in Kaifeng (Investigational 23-valent PPV, Control 23-valent PPV)
Completed
- Pneumococcal Infections
- Investigational 23-valent PPV
- Control 23-valent PPV
-
Kaifeng, Henan, ChinaKaifeng County Center for Disease Control and Prevention
Aug 10, 2022
Ebola Sudan Virus Disease Trial in Siaya, Kampala (cAD3-Sudan Ebolavirus Vaccine, Placebo)
Not yet recruiting
- Ebola Sudan Virus Disease
- cAD3-Sudan Ebolavirus Vaccine
- Placebo
-
Siaya, Kenya
- +1 more
Sep 7, 2023